These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35796459)

  • 1. Pharmacological inhibitors of autophagy have opposite effects in acute and chronic cisplatin-induced kidney injury.
    Sears SM; Feng JL; Orwick A; Vega AA; Krueger AM; Shah PP; Doll MA; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2022 Sep; 323(3):F288-F298. PubMed ID: 35796459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of low-dose cisplatin in mice induces fibrosis.
    Sharp CN; Doll MA; Dupre TV; Shah PP; Subathra M; Siow D; Arteel GE; Megyesi J; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2016 Mar; 310(6):F560-8. PubMed ID: 26739893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity.
    Orwick A; Sears SM; Sharp CN; Doll MA; Shah PP; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2023 Mar; 324(3):F287-F300. PubMed ID: 36727944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
    Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
    Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury.
    Sears SM; Sharp CN; Krueger A; Oropilla GB; Saforo D; Doll MA; Megyesi J; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F674-F685. PubMed ID: 32830540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in proximal tubules protects against acute kidney injury.
    Jiang M; Wei Q; Dong G; Komatsu M; Su Y; Dong Z
    Kidney Int; 2012 Dec; 82(12):1271-83. PubMed ID: 22854643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease.
    Sharp CN; Doll MA; Megyesi J; Oropilla GB; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2018 Jul; 315(1):F161-F172. PubMed ID: 29384415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells.
    Liu J; Livingston MJ; Dong G; Tang C; Su Y; Wu G; Yin XM; Dong Z
    Cell Death Dis; 2018 Feb; 9(3):322. PubMed ID: 29476062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative DNA damage by repeated low-dose cisplatin injection promotes the transition of acute to chronic kidney injury in mice.
    Yamashita N; Nakai K; Nakata T; Nakamura I; Kirita Y; Matoba S; Humphreys BD; Tamagaki K; Kusaba T
    Sci Rep; 2021 Oct; 11(1):20920. PubMed ID: 34686727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration.
    Sharp CN; Doll M; Dupre TV; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F162-F172. PubMed ID: 30484347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury.
    Wang Y; Tang C; Cai J; Chen G; Zhang D; Zhang Z; Dong Z
    Cell Death Dis; 2018 Nov; 9(11):1113. PubMed ID: 30385753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin Is Not Protective against Ischemic and Cisplatin-Induced Kidney Injury.
    Andrianova NV; Zorova LD; Babenko VA; Pevzner IB; Popkov VA; Silachev DN; Plotnikov EY; Zorov DB
    Biochemistry (Mosc); 2019 Dec; 84(12):1502-1512. PubMed ID: 31870254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin protects from cisplatin-induced acute kidney injury.
    Dupre TV; Doll MA; Shah PP; Sharp CN; Kiefer A; Scherzer MT; Saurabh K; Saforo D; Siow D; Casson L; Arteel GE; Jenson AB; Megyesi J; Schnellmann RG; Beverly LJ; Siskind LJ
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F248-58. PubMed ID: 26661653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction.
    Li J; Gui Y; Ren J; Liu X; Feng Y; Zeng Z; He W; Yang J; Dai C
    Sci Rep; 2016 Apr; 6():23975. PubMed ID: 27052588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing better mouse models to study cisplatin-induced kidney injury.
    Sharp CN; Siskind LJ
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F835-F841. PubMed ID: 28724610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity.
    Ranganathan P; Hamad R; Mohamed R; Jayakumar C; Muthusamy T; Ramesh G
    Kidney Int; 2016 Feb; 89(2):317-26. PubMed ID: 26509586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and involvement of p53 in cisplatin-induced nephrotoxicity.
    Wei Q; Dong G; Yang T; Megyesi J; Price PM; Dong Z
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1282-91. PubMed ID: 17670903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Cisplatin-Induced Kidney Injury to Increase Translational Potential.
    Sears SM; Orwick A; Siskind LJ
    Nephron; 2023; 147(1):13-16. PubMed ID: 35793615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury.
    Zhu L; Yuan Y; Yuan L; Li L; Liu F; Liu J; Chen Y; Lu Y; Cheng J
    Theranostics; 2020; 10(13):5829-5844. PubMed ID: 32483422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.